Selvita is a preclinical CRO providing multidisciplinary support in resolving the unique challenges of research within the areas of drug discovery and drug development.
The company offers support at every stage of the early discovery phase up to the preclinical development. Selvita specializes in a variety of processes from in silico drug design and synthesis of a target-focused library, to complex preclinical in vitro and in vivo pharmacology, and structural biology.